Oscar Saavedra

Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases

Stephen Claridge, Franck Raeppel, Marie‐Claude Granger et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Michael R. Mannion, Stéphane Raeppel, Stephen Claridge et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors

Isabelle Paquin, Stéphane Raeppel, Silvana Leit et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Stéphane Raeppel, Stephen Claridge, Oscar Saavedra et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

N3-Arylmalonamides: A new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinases

Oscar Saavedra, Stephen Claridge, Lijie Zhan et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10